Genetic testing for escitalopram in community pharmacy
This study tests how a person's genetic makeup affects their response to the antidepressant escitalopram (Lexapro). It takes place at a community pharmacy and aims to help personalize treatment for depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are starting escitalopram (brand name Lexapro) for depression, with or without anxiety.
- You have not taken escitalopram before for this condition.
- You are able to understand and follow the study's instructions.
- You agree to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether doing genetic testing before starting or adjusting antidepressants—guided by a pharmacist—can improve treatment for people with moderate to severe depression. The goal is to help match you with antidepressants more safely and effectively.
This trial tests whether a pharmacist can use your genetic information to better manage your depression medications. It may help find the right drug or dose for you.
This study looks at whether a genetic test can help choose the best antidepressant for you. It aims to make treatment more personalized and effective for people with depression.
This study tests whether a genetics-guided approach to choosing and adjusting escitalopram (an anxiety medicine) can improve safety and effectiveness for anxious teens. It also checks that participants have certain anxiety severity scores and can safely take the study medication.
This study tests whether using a cheek swab DNA test can help choose a better antidepressant for teenagers with anxiety or depression. The goal is to see if this personalized approach leads to fewer side effects and better results.
This study tests if using genetic information can help doctors choose the right mental health medication or dose. It may help find treatments that work better with fewer side effects.
Hear when a new Pharmacogenetic Testing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.